XML 42 R18.htm IDEA: XBRL DOCUMENT v2.4.0.8
Fair Value Measurements
6 Months Ended
Jun. 30, 2014
Fair Value Disclosures [Abstract]  
Fair Value Measurements
Fair Value Measurements
The following table presents the Company’s hierarchy for its assets and liabilities measured at fair value on a recurring basis as of the following periods (in thousands):
 
 
June 30, 2014
 
December 31, 2013
 
Level 1
 
Level 2
 
Level 3
 
Total
 
Level 1
 
Level 2
 
Level 3
 
Total
Assets:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash equivalents
$
3,055

 
$

 
$

 
$
3,055

 
$
3,056

 
$

 
$

 
$
3,056

Total assets measured at fair value
$
3,055

 
$

 
$

 
$
3,055

 
$
3,056

 
$

 
$

 
$
3,056

Liabilities:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Senior Credit Facility
$

 
$

 
$

 
$

 
$

 
$

 
$

 
$

Contingent consideration

 

 
7,735

 
7,735

 

 

 
8,808

 
8,808

Total liabilities measured at fair value
$

 
$

 
$
7,735

 
$
7,735

 
$

 
$

 
$
8,808

 
$
8,808


There were no transfers of assets or liabilities between Level 1, Level 2 and Level 3 categories of the fair value hierarchy during the three and six month period ended June 30, 2014 and the year ended December 31, 2013.
The Company used Level 1 inputs to determine the fair value of its cash equivalents, which primarily consist of funds held in a money market account, and as such, the carrying value of cash equivalents approximates fair value. As of June 30, 2014 and December 31, 2013, the carrying value of cash equivalents was $3.1 million. There were no borrowings under the Senior Credit Facility as of June 30, 2014 and December 31, 2013.
The Company reassesses the fair value of contingent consideration to be settled in cash related to acquisitions on a quarterly basis using the Monte Carlo Simulation Model for the royalty earn-out portions of the contingent liability and probability weighted models for the research and development earn-out. These are Level 3 measurements. Significant assumptions used in the measurement include probabilities of achieving the remaining milestones and the discount rates, which depend on the milestone risk profiles. Due to changes in the estimated payments and a shorter discounting period, the fair value of the contingent consideration liabilities changed, resulting in a $42,000 loss recorded in research and development expense in the Consolidated Statements of Operations during the three and six months ended June 30, 2014.
Changes in estimated fair value of contingent consideration liabilities from December 31, 2013 through June 30, 2014 are as follows (in thousands):
 

Contingent consideration liabilities
(Level 3 measurement)
Balance at December 31, 2013
$
8,808

Cash payments
(1,116
)
Losses recorded for fair value adjustments
42

Unrealized loss on foreign currency translation
1

Balance at June 30, 2014
$
7,735